BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32157927)

  • 21. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
    Colazingari S; Treglia M; Najjar R; Bevilacqua A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1405-11. PubMed ID: 23708322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M; Nordio M; Pajalich R
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism.
    Yang W; Yang R; Yang S; Li J; Tu B; Gao C; Wang Y
    Gynecol Endocrinol; 2018 Aug; 34(8):715-718. PubMed ID: 29376451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of infertility in polycystic ovary syndrome: a brief update.
    Costello MF; Misso ML; Wong J; Hart R; Rombauts L; Melder A; Norman RJ; Teede HJ
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):400-3. PubMed ID: 22639834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of α-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study.
    Novielli C; Anelli GM; Lisso F; Marzorati A; Parrilla B; Oneta M; Savasi VM; Cetin I; Mandò C
    Reprod Biol; 2020 Dec; 20(4):541-546. PubMed ID: 33371944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials.
    Laganà AS; Vitagliano A; Noventa M; Ambrosini G; D'Anna R
    Arch Gynecol Obstet; 2018 Oct; 298(4):675-684. PubMed ID: 30078122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
    Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
    Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
    Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovulation induction in polycystic ovary syndrome.
    Vause TDR; Cheung AP;
    J Obstet Gynaecol Can; 2010 May; 32(5):495-502. PubMed ID: 20500959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
    Morgante G; Orvieto R; Di Sabatino A; Musacchio MC; De Leo V
    Fertil Steril; 2011 Jun; 95(8):2642-4. PubMed ID: 21300338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovulation induction in polycystic ovary syndrome.
    Tanbo T; Mellembakken J; Bjercke S; Ring E; Åbyholm T; Fedorcsak P
    Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1162-1167. PubMed ID: 29889977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
    Okohue JE; Onuh SO; Ikimalo JI
    Niger J Clin Pract; 2013; 16(2):207-10. PubMed ID: 23563463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of FT500 Plus(®) on ovarian stimulation in PCOS women.
    Alviggi C; Cariati F; Conforti A; De Rosa P; Vallone R; Strina I; Pivonello R; De Placido G
    Reprod Toxicol; 2016 Jan; 59():40-4. PubMed ID: 26545973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relevance of inositols treatment for PCOS before and during ART.
    Artini PG; Malacarne E; Tomatis V; Genazzani AD
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4799-4809. PubMed ID: 34337729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
    Pericuesta E; Laguna-Barraza R; Ramos-Ibeas P; Gutierrez-Arroyo JL; Navarro JA; Vera K; Sanjuan C; Baixeras E; de Fonseca FR; Gutierrez-Adan A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
    Mendoza N; Galan MI; Molina C; Mendoza-Tesarik R; Conde C; Mazheika M; Diaz-Ropero MP; Fonolla J; Tesarik J; Olivares M
    Gynecol Endocrinol; 2020 May; 36(5):398-401. PubMed ID: 31657275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovulation induction management of PCOS.
    Guzick DS
    Clin Obstet Gynecol; 2007 Mar; 50(1):255-67. PubMed ID: 17304040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.